Galectin Therapeutics Correlations

GALT Stock  USD 1.59  0.06  3.92%   
The current 90-days correlation between Galectin Therapeutics and DiaMedica Therapeutics is 0.17 (i.e., Average diversification). The correlation of Galectin Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Galectin Therapeutics Correlation With Market

Good diversification

The correlation between Galectin Therapeutics and DJI is -0.08 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Galectin Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Galectin Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For more information on how to buy Galectin Stock please use our How to Invest in Galectin Therapeutics guide.

Moving together with Galectin Stock

  0.64LUCD Lucid DiagnosticsPairCorr
  0.68JNJ Johnson Johnson Sell-off TrendPairCorr
  0.66T ATT Inc Sell-off TrendPairCorr

Moving against Galectin Stock

  0.7ASMB Assembly Biosciences Earnings Call This WeekPairCorr
  0.68CMND Clearmind Medicine CommonPairCorr
  0.59SCLX Scilex HoldingPairCorr
  0.54CDIOW Cardio DiagnosticsPairCorr
  0.47ELVN Enliven TherapeuticsPairCorr
  0.4CRNX Crinetics PharmaceuticalsPairCorr
  0.37CDIO Cardio DiagnosticsPairCorr
  0.36MLSS Milestone Scientific Earnings Call This WeekPairCorr
  0.57CAT CaterpillarPairCorr
  0.56MSFT Microsoft Aggressive PushPairCorr
  0.5HD Home DepotPairCorr
  0.5DIS Walt DisneyPairCorr
  0.37BA BoeingPairCorr
  0.35MRK Merck CompanyPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
HEPAVKTX
HEPASRPT
SRPTVKTX
AKROMDGL
TERNVKTX
DMACAKRO
  
High negative correlations   
PTCTSRPT
PTCTHEPA
PTCTVKTX
AKROTERN
AKROHEPA
AKROVKTX

Risk-Adjusted Indicators

There is a big difference between Galectin Stock performing well and Galectin Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Galectin Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
MDGL  2.99  0.28  0.07  0.21  3.97 
 7.64 
 23.14 
VKTX  3.51 (0.53) 0.00  0.60  0.00 
 7.71 
 24.65 
SRPT  2.37 (0.70) 0.00  0.70  0.00 
 4.28 
 32.12 
HEPA  10.24 (4.16) 0.00  31.46  0.00 
 16.37 
 90.05 
PTCT  1.78  0.39  0.20 (1.93) 1.82 
 4.33 
 13.60 
ICPT  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
TERN  3.07 (0.93) 0.00 (0.94) 0.00 
 5.03 
 19.13 
AKRO  4.31  1.20  0.35  0.73  2.88 
 4.92 
 104.81 
RETA  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
DMAC  2.59 (0.04) 0.00 (0.23) 0.00 
 5.39 
 20.98 

Galectin Therapeutics Corporate Management

CPA CPATreasurer CFOProfile
Khurram MDChief OfficerProfile
Jeff KatstraHead DevelopmentProfile
Robert TrittGeneral CounselProfile
Beth KnowlesExecutive ManagerProfile